FDA Inspection 1170855 — Interfarma Corp.

Interfarma Corp. — FEI 3003605812

The FDA completed an inspection of Interfarma Corp. on Jun 2, 2022 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 2, 2022
Fiscal Year
2022
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Miami, FL (United States)

Citations

IDCFRDescription
1553121 CFR 111.255(a)Batch record - every batch
1576221 CFR 111.205(a)Master manufacturing record - each batch
1583921 CFR 111.70(e)Specifications - identity, purity, strength, composition
1584321 CFR 111.70(g)Specifications - finished packaging, labeling
1589721 CFR 111.83(a)Reserve sample - collect, hold
1593321 CFR 111.105(b)Quality control - supplier qualification